Bounce Mobile System (BNCM)

[Humbert]

Personally, I think we should see an official market cap closer to $1B, but the float is likely to remain quite small. So, in that sense, the market cap won't tell the full story - shares are scarce.

[Humbert]

For drug manufacturers in the US, the P/S ratio is about 6x.

If we add the fact that it's in a developing market, you can look at 8x, but even that is conservative. Also, even though there are quite a few shares out, the float is very small, and will remain small. As you can see, there isn't any dilution, and many shares are restricted, will stay restricted, or be retired.

So market cap may not be the best way to view things. However, conservatively, a market cap of $400,000,000 - $500,000,000 seems reasonable. If the float is tight, could be much higher - a dividend could also lead to significant appreciation.

[tedpeele]

Is anyone predicting market cap potential here?

[Humbert]

Well, anyone who sells here is nuts. IR aside, the deal here is a certainty.

[HokieHead]

Lmao.

[richme]

Doesn't look like it is going to go up either!!!!

[janetcanada]

👀***BNCM- Link to the trades:.....
***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-BNCM/trades

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/BNCM/overview

[HokieHead]

Lmao, no sellers..

[Humbert]

Q3 report at the latest.

[JJZander]

Q3

[tedpeele]

when will revenues be revealed?

..

[Humbert]

Well, people are trying to buy cheapies, but, if they want to get in before the major catalysts hit, they'll need to pay up. It ain't going lower than this.

[mzasif]

We basically need updates in these areas before the stock will see any excitement which will eventually drive the stock to move up to its real price value of multiple dollars...period!

[rbb]

Monday morning standoff...

[HokieHead]

Can’t wait for it all to unfold. I would guess Delex could be doing around $50m in sales for year ended 2024 at least. The current tradeable float now, and most likely post merger due to restricted shares, valued at about $700,000 here 😆. Completely undervalued with what’s coming. Easily a multiple dollar ticker ahead imo.

[Humbert]

Financials, name/ticker change, official transfer of control - all to occur in the coming weeks/months.

[trademax42]

Good morning everyone!! Expecting a good day in the BNCM land.

best.........

[mzasif]

Yes Sir! You missed this part of my message that I added later LOLOL
Get ready for KABOOM KABASH💥🤯🥳😎

[HokieHead]

Delex is a beast, can’t wait as this all unfolds in Q4.

[mzasif]

Check this out! Directly from JMN Brother Pharma's official website;
https://jmnbrotherspharma.com/about-us-v1/
JMN Brothers Pharma Limited, Inc. confidently operates as one of the trusted newly organized Filipino-owned and managed pharmaceutical companies. It has established its name by providing holistic wellness and beauty solutions to its niche market since 2018. The industry has competitively delved into the field through the comprehensive plans and initiatives of its accomplished and committed leaders.

The company is a subsidiary of Delex Pharma International Inc., which is among the fastest-growing pharmaceutical industries in the country. Moreover, it was ranked as the number five (5) National Company in the hospital sector according to the IQVIA MAT report in December 2019. Thus, it boosts the quality service JMN Pharma is exhibiting to its stakeholders and customers.

Get ready for KABOOM KABASH💥🤯🥳😎

[Humbert]

Facebook page for JMN - looks impressive.

[Humbert]

Great news, hinting that the higher estimates for the financials may be closer to the mark. I think we could possibly see ~$50mm reported, or more.

JMN's products look poised to make a huge impact.

People can read the rest here: https://www.otcmarkets.com/stock/BNCM/news/BNCM-DELEX-Acquisition-of-JMN-BROTHERS-PHARMA-will-fuel-its-Market-Growth?id=453611

[JJZander]

BNCM: DELEX Acquisition of JMN BROTHERS PHARMA will fuel its Market Growth
Press Release | 09/22/2024
September 2024 DELEX Pharma International, Inc. has acquired JMN Brothers Pharma Limited, Inc. (JMN Pharma) in 2022. JMN Pharma was established in 2018 and known for its expertise in Women's Health and Beauty, along with its ethical business in hospital products. The company is led by experienced executives from multinational pharmaceutical organizations. This strategic acquisition is projected to account for 20% of DELEX Pharma's total corporate revenue, further strengthening its position in the over-the-counter (OTC) healthcare market.

[Humbert]

Huge news, big things on the horizon

[dinogreeves]

BNCM has news, before bright and early.... break dime land tomorrow.

[HokieHead]

New highs this week.

[mzasif]

As Hokie has repeatedly said, this has the potential to run like FCCN with the float we have today. I have no doubt it will... another ticker that took off recently into multiple dollars is FRZO.

Let's see what kind of news will come out this week for us.

[Humbert]

The stock traded at $1.70 in 2021, and the float hasn't changed much since then. The potential here is massive for those who know.

[trademax42]

Yup waiting for great things to come. Its a matter of time and a bit of patience, not if. imo

[mzasif]

Waiting for all the great things to unfold within next 90 days....we will get to dollars in this coming weeks and months before year end 2024.

[Humbert]

Should have a nice week ahead

[mzasif]

I like things when they are real 😁

[Humbert]

Back to .08s, likely touch .10s next week.

[janetcanada]

👀***BNCM- Link to the trades:.....
***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-BNCM/trades

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/BNCM/overview

[HokieHead]

Things about to get real 😉

[Humbert]

Major news should hit early next week.

As the facts come into view, we'll doubtlessly continue to trend higher and higher.

[rbb]

nice news, no shortage of updates here... thinking we start seeing bigger updates this week... $BNCM

[richme]

That and threats of a lawsuit. I contributed $200.
Best stock I ever bought.

[janetcanada]

👀***BNCM *** "Yes I do and did not forget the Complaints to the SEC!.....The Company had to Pay"......

[HokieHead]

Lmao.

[Beauneedsbiscuits]

Form T broker sales..interesting..watching to see if those become significant amounts!

[richme]

I once had a stock that went bally up. Only by the grace of God did the shares end up in significant profit! Remember?

[Poundthetable]

You learn something new every day…

[richme]

Thanks for the lesson.

[HokieHead]

b I n g o… 🔥

[trademax42]

Good morning everyone! Thanks JJZ for the info.

[janetcanada]

👀***BNCM- What Really Count is Trust in the Company!.....🍀

👀***Bid Price/Ask Price

❗️***The Term "Bid" Refers to the Highest Price a Buyer Will Pay to Buy a specified number of shares of a stock at any given time. The Term "Ask" Refers to the Lowest Price at Which a Seller will Sell the Stock.

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/BNCM/overview

[F14SVF24]

As for someone who worked for a company that performed repairs and modifications on Airbus Aircraft being ISO 9001 certified is a huge deal for a business. Very strict guidelines covering all aspects of the business. It tells all potential clients and vendors "You can trust us". They will be audited every year for continued compliance.

[mzasif]

Good News after Good News ~ Go BNCM / DELEX!!!
Thank you JJZ.

[JJZander]

News!

2024-09-20 | Press Release
CPG Awards ISO 9001:2015 Re-certification to Delex, Unlocks Global Market
cpg-awards-iso-90012015-re-certification-to-delex-unlocks-global-market
September 20, 2024 – Quezon City, Philippines – Delex Pharma International, Inc. (DPI) has once again demonstrated its unwavering commitment to quality and customer satisfaction by successfully passing the ISO 9001:2015 re-certification audit. The evaluation, conducted by Certification Partner Global (CPG), a leading international auditing firm, took place on July 12, 2024. Today, the certificate handover ceremony materialized at DPI's head office.

During the handover ceremony, Ms. Lanie Olbita, CPG Country Manager, presented the re-certification to the Delex Pharma ISO officers. Receiving the prestigious certificate on behalf of the company were Mr. J. de Ruyter C. Oroceo, CEO & Chairman of the Board, who also serves as the Quality Council Chairman, and Ms. Nilda Cruz, Quality Management Representative.

Elevating the Standards of Customer Satisfaction
On July 6, 2021, Delex Pharma proudly achieved its ISO 9001:2015 certification, marking a significant milestone in the company's journey toward operational excellence. This certification has streamlined the company’s business processes, enhancing efficiency, effectiveness, and full compliance with statutory and regulatory requirements. By aligning with international benchmarks, DPI further strengthens its ability to deliver high-quality products and services, ensuring satisfaction for both external and internal customers.

Reflecting on this achievement, Mr. J. de Ruyter C. Oroceo stated, "ISO 9001:2015 is a crucial milestone that has significantly improved our business processes." He emphasized the importance of performance monitoring, evaluation, and ongoing improvement, adding, "A business process is not truly complete if we stop at planning. It requires the full application of the Plan-Do-Check-Act (PDCA) cycle to drive continuous progress."

Access to Global Market
Delex Pharma is steadfast in continuously improving its quality management system as it works towards meeting global standards and providing better healthcare solutions. As Ms. Nilda Cruz, the organization’s Quality Management Representative, explained, "Many industries and countries require ISO certification as a prerequisite for doing international business. Meeting ISO standards opens doors to new markets and enhances global competitiveness."

Embodying Continuous Improvement
With a strong focus on ongoing progress, DPI will conduct its next ISO internal audit in November this year. This audit will assess the effectiveness of its Quality Management System following the recent re-certification, ensuring the company remains on track toward continuous improvement.